Baxter Stock May Gain Following Five New Injectable Product Launches

Baxter International (BAX) recently announced the launch of five new injectable pharmaceutical products in the United States, which, when combined with the previous five launches announced in April 2024, marks a total of 10 U.S. injectable product launches in 2024.These new launches reinforce Baxter’s leadership in bringing high-value, specialty injectable products to market to help address critical patient needs. The launches further strengthen Baxter’s Pharamaceutical business segment.Likely Trend of BAX ...